Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Comparison of the α2/3/5 Selective Positive Allosteric Modulators L-838,417 and TPA023 in Preclinical Models of Inflammatory and Neuropathic Pain.
Nickolls S, Mace H, Fish R, Edye M, Gurrell R, Ivarsson M, Pitcher T, Tanimoto-Mori S, Richardson D, Sweatman C, Nicholson J, Ward C, Jinks J, Bell C, Young K, Rees H, Moss A, Kinloch R, McMurray G. Nickolls S, et al. Among authors: mcmurray g. Adv Pharmacol Sci. 2011;2011:608912. doi: 10.1155/2011/608912. Epub 2011 Nov 28. Adv Pharmacol Sci. 2011. PMID: 22162674 Free PMC article.
Targeting fatty acid amide hydrolase as a therapeutic strategy for antitussive therapy.
Wortley MA, Adcock JJ, Dubuis ED, Maher SA, Bonvini SJ, Delescluse I, Kinloch R, McMurray G, Perros-Huguet C, Papakosta M, Birrell MA, Belvisi MG. Wortley MA, et al. Among authors: mcmurray g. Eur Respir J. 2017 Sep 20;50(3):1700782. doi: 10.1183/13993003.00782-2017. Print 2017 Sep. Eur Respir J. 2017. PMID: 28931663 Free article.
Pharmacological properties of 2-((R-5-chloro-4-methoxymethylindan-1-yl)-1H-imidazole (PF-3774076), a novel and selective alpha1A-adrenergic partial agonist, in in vitro and in vivo models of urethral function.
Conlon K, Christy C, Westbrook S, Whitlock G, Roberts L, Stobie A, McMurray G. Conlon K, et al. Among authors: mcmurray g. J Pharmacol Exp Ther. 2009 Sep;330(3):892-901. doi: 10.1124/jpet.109.154963. Epub 2009 Jun 4. J Pharmacol Exp Ther. 2009. PMID: 19498105
Pyrimido[4,5-d]azepines as potent and selective 5-HT2C receptor agonists: design, synthesis, and evaluation of PF-3246799 as a treatment for urinary incontinence.
Andrews MD, Fish PV, Blagg J, Brabham TK, Brennan PE, Bridgeland A, Brown AD, Bungay PJ, Conlon KM, Edmunds NJ, af Forselles K, Gibbons CP, Green MP, Hanton G, Holbrook M, Jessiman AS, McIntosh K, McMurray G, Nichols CL, Root JA, Storer RI, Sutton MR, Ward RV, Westbrook D, Whitlock GA. Andrews MD, et al. Among authors: mcmurray g. Bioorg Med Chem Lett. 2011 May 1;21(9):2715-20. doi: 10.1016/j.bmcl.2010.11.120. Epub 2010 Dec 4. Bioorg Med Chem Lett. 2011. PMID: 21195614
Design and synthesis of piperazinylpyrimidinones as novel selective 5-HT(2C) agonists.
Andrews MD, Green MP, Allerton CM, Batchelor DV, Blagg J, Brown AD, Gordon DW, McMurray G, Millns DJ, Nichols CL, Watson L. Andrews MD, et al. Among authors: mcmurray g. Bioorg Med Chem Lett. 2009 Sep 15;19(18):5346-50. doi: 10.1016/j.bmcl.2009.07.133. Epub 2009 Aug 6. Bioorg Med Chem Lett. 2009. PMID: 19692241
69 results